{"schema_version":"secwatch.filing_event.v1","accession":"0000034067-24-000103","form_type":"8-K","ticker":"BOOM","cik":"0000034067","company_name":"DMC Global Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.554971+00:00","generated_at":"2026-06-01T06:04:36.857595+00:00","sec_items":["1.01","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"DMC Global adopts poison pill with 10% trigger; continues strategic review of two units","bullets":["Rights plan effective June 5, 2024, expires June 4, 2025; one right per share as of June 17, 2024.","Trigger at 10% (20% for passive investors); upon trigger, rights allow purchase of shares at $75 with 2x market value.","Board may exchange one common share per right (excluding triggering person) after trigger event.","Board continuing strategic review of DynaEnergetics and NobelClad, considering sale, merger, or investment."],"urls":{"canonical":"https://secwatch.observer/filing/0000034067-24-000103","json":"https://secwatch.observer/filing/0000034067-24-000103.json","markdown":"https://secwatch.observer/filing/0000034067-24-000103.md","text":"https://secwatch.observer/filing/0000034067-24-000103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34067/000003406724000103/0000034067-24-000103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34067/000003406724000103/boom-20240605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T06:04:36.857595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}